GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 87 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $143,000 | +64.4% | 5,985 | 0.0% | 0.01% | +25.0% |
| Q4 2020 | $87,000 | +2.4% | 5,985 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $85,000 | -3.4% | 5,985 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $88,000 | +486.7% | 5,985 | +60.5% | 0.00% | +300.0% |
| Q1 2020 | $15,000 | -16.7% | 3,729 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $18,000 | -21.7% | 3,729 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $23,000 | -4.2% | 3,729 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $24,000 | -7.7% | 3,729 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $26,000 | +44.4% | 3,729 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $18,000 | -33.3% | 3,729 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $27,000 | +12.5% | 3,729 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $24,000 | +20.0% | 3,729 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $20,000 | +25.0% | 3,729 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $16,000 | -55.6% | 3,729 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $36,000 | -18.2% | 3,729 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $44,000 | -8.3% | 3,729 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $48,000 | – | 3,729 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|